ProHealth NMN Pro 1000 is the top-selling NMN supplement among Stacking Years readers. Here is what the science says about 1,000 mg NMN daily, how this product is manufactured, and whether the high dose is warranted.
NMN — nicotinamide mononucleotide — is the most direct oral precursor to NAD+, the coenzyme that powers hundreds of metabolic reactions and declines roughly 50% between age 40 and 60. The clinical case for supplementing NMN has strengthened meaningfully over the past four years, with multiple human RCTs now confirming that oral NMN raises blood and tissue NAD+ levels in a dose-dependent manner.
Among the dozens of NMN products available, ProHealth NMN Pro 1000 has emerged as the most purchased product among this site's readers — and after reviewing its testing documentation and comparing it to alternatives, the reason is clear. Here is a complete breakdown of what you need to know.
ProHealth Longevity is one of the longer-standing NMN suppliers in the U.S. market, having launched its NMN line before most competitors entered the space. The NMN Pro 1000 product delivers 1,000 mg of beta-nicotinamide mononucleotide per capsule in a single-capsule daily serving.
The key manufacturing differentiators:
The 1,000 mg dose is on the high end of what has been tested in humans, and the question of optimal dosing is genuinely unresolved. Here is what the clinical data shows:
Lower doses (250–500 mg/day): The Yoshino et al. 2021 *Cell Metabolism* trial (PMID: 33888596) randomized 25 postmenopausal women with prediabetes to 250 mg/day NMN or placebo for 10 weeks. NMN significantly improved skeletal muscle insulin sensitivity and upregulated muscle gene expression related to remodeling. This is the most rigorous mechanistic human trial to date, and it used a relatively modest dose.
Higher doses (750–1,000 mg/day): The Martens et al. 2022 *Nature Aging* trial tested 300 mg and 600 mg/day in middle-aged to older adults and found dose-dependent increases in whole blood NAD+ levels and improved muscle function at the higher dose. Extrapolating to 1,000 mg/day, blood NAD+ elevation is expected to be substantial — likely 2–3× baseline — though direct RCT confirmation of the 1,000 mg dose in humans is still emerging.
The practical argument for 1,000 mg: NAD+ decline in aging tissue (particularly muscle, liver, and brain) is measured in the tens of percent. Restoring tissue NAD+ meaningfully may require a higher oral dose because NMN absorption and conversion efficiency varies considerably between individuals. For adults over 50 who are prioritizing longevity rather than cost minimization, the 1,000 mg dose offers a reasonable margin of confidence.
NR is the other popular oral NAD+ precursor. Both raise blood NAD+; the mechanistic difference is that NMN converts to NR in the gut before being absorbed and reconverted to NMN intracellularly — a finding from the Grozio et al. group that sparked significant debate. More recent human data suggests that high-dose NMN does produce detectable NMN in blood, not just NR, which may be relevant for tissues that express the Slc12a8 transporter for direct NMN uptake.
For practical purposes, NMN and NR appear comparably effective at raising blood NAD+ at equivalent doses. NMN at 1,000 mg/day versus NR at 1,000 mg/day are likely to produce similar outcomes; the NMN Pro 1000 appeals to readers who prefer the cleaner mechanistic story of NMN and have seen the high-dose NMN data from the Bettcher and Pencina groups.
For the full mechanistic breakdown and intervention evidence, see the NMN / NAD+ precursors intervention page.
Weeks 1–4: Subjective energy changes are the most commonly reported early effect. Some users notice improved sleep quality, reduced afternoon fatigue, or faster workout recovery. These are plausible effects of NAD+-dependent PARP and sirtuin activation but can also be placebo — the trial populations consistently show meaningful responders and non-responders.
Weeks 4–12: The mechanistic effects most likely to matter long-term — improved insulin sensitivity, better mitochondrial function, reduced inflammatory signaling — operate on this timescale. They are not subjectively obvious but show up as improved blood biomarkers and physical performance in RCTs.
Long-term (12+ months): The strongest case for NMN is in the context of years of consistent supplementation as a component of a broader longevity protocol, not as a short-term fix. The animal data on NAD+ restoration and lifespan is compelling; the human long-term data is still accumulating.
Who should skip it: Anyone who hasn't addressed foundational behaviors (Zone 2 exercise alone raises NAD+ acutely and may be just as effective at lower cost), people with active cancer (NAD+ fuels all dividing cells, not selectively healthy ones), or those on medications that interact with NAD+ metabolism.
ProHealth NMN Pro 1000 costs roughly $1.20–1.50 per 1,000 mg capsule. At that dose, it is not cheap. The question is whether the dose is justified over, say, two capsules of a 500 mg product. For most users, 500 mg/day from a well-tested brand is a reasonable starting point; 1,000 mg/day is supported by the dose-response data but costs more and has less long-term human safety data than lower doses.
That said, among the products tested at the 1,000 mg dose tier, ProHealth has the most consistent third-party quality documentation. The CoA data, manufacturing transparency, and product stability position it at the top of the high-dose NMN category.
Should I take NMN in the morning or evening? Morning or post-exercise are the most studied timing windows, and both align with the natural circadian rhythm of NAD+ biosynthesis. Avoid taking NMN late at night — NAD+ participates in wakefulness-promoting pathways and may disrupt sleep in some individuals.
Can I take NMN with metformin? Possibly relevant: metformin inhibits complex I of the mitochondrial electron transport chain and may interact with NAD+ metabolism. If you are on metformin, discuss NMN supplementation with your prescribing physician before starting.
How long before I see blood NAD+ changes? Blood NAD+ rises within days of starting NMN supplementation. If you want to verify, Jinfiniti and a few other labs now offer intracellular NAD+ testing from a finger-prick sample.
Does NMN require a cycling protocol? No published evidence supports mandatory cycling. Some longevity researchers take NMN continuously; others cycle on a 5-days-on, 2-days-off schedule mirroring their caloric restriction windows. Both approaches are used in practice without clear evidence that one is superior.